FDA Issues Co-Development Guidance, But Only For Products Treating "Serious" Diseases
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Commissioner Hamburg and CDER Director Woodcock outline the requirements for developing drugs in combination during the Faster Cures Partnering for Cures meeting in New York.